AM-x Synthetic Cannabinoids Cannabinoid Research

AM-x Synthetic Cannabinoids Research Dashboard

97

Primary Studies

65

Related Studies

162

Total Studies

Clinical Studies

0

Double-blind human trials

0

Clinical human trials

Pre-Clinical Studies

2

Meta-analyses/Reviews

69

Animal studies

17

Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 162 studies associated with AM-x Synthetic Cannabinoids.

Here is a small sampling of AM-x Synthetic Cannabinoids studies by title:


Components of the AM-x Synthetic Cannabinoids Research Dashboard

  • Top medical conditions associated with AM-x Synthetic Cannabinoids
  • Proven effects in clinical trials for AM-x Synthetic Cannabinoids
  • Receptors associated with AM-x Synthetic Cannabinoids
  • Individual study details for AM-x Synthetic Cannabinoids

Ready to become a subscriber? Go to our PRICING page.

Select New Cannabinoid

Filter Cannabinoid

Members can filter by the following criteria:

  • Study Type
  • Organ Systems
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - AM-x Synthetic Cannabinoids

Description of AM-x Synthetic Cannabinoids

The AM class of synthetic cannabinoids are named after their producer, Alexandros Makriyannis, a professor at Northeastern University in Boston. This class of cannabinoids can produce a variety of different effects. A prominent example is AM-251.

Other Names:

AM Family Synthetic Cannabinoids

AM-x Synthetic Cannabinoids Properties and Effects

May have apoptotic properties in human cutaneous melanoma.

AM-x Synthetic Cannabinoids Receptor Binding

Full antagonist and strong affinity at CB1 (Ki 7.5nM). Weak affinity and agonist at GPR-55. μ-opioid receptor antagonist (Ki = 251 nM)

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.